Free Trial

EssilorLuxottica (OTCMKTS:ESLOY) Sees Strong Trading Volume - Here's What Happened

EssilorLuxottica logo with Medical background

Shares of EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY - Get Free Report) saw unusually-high trading volume on Tuesday . Approximately 123,116 shares changed hands during mid-day trading, an increase of 227% from the previous session's volume of 37,654 shares.The stock last traded at $140.61 and had previously closed at $139.97.

EssilorLuxottica Price Performance

The company has a quick ratio of 0.65, a current ratio of 0.95 and a debt-to-equity ratio of 0.17. The company has a fifty day moving average of $142.14 and a two-hundred day moving average of $137.97.

EssilorLuxottica Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Thursday, June 26th. Investors of record on Tuesday, May 13th will be issued a dividend of $1.833 per share. This represents a dividend yield of 1.26%. The ex-dividend date is Monday, May 12th.

About EssilorLuxottica

(Get Free Report)

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EssilorLuxottica Right Now?

Before you consider EssilorLuxottica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EssilorLuxottica wasn't on the list.

While EssilorLuxottica currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next Palantir? AI-Defense Stock Set for Explosive Growth
2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines